C.M.L. was also supported in part by EGFR RESISTERS/LUNGEVITY Lung Cancer Research Award, P30-CA086485, UG1CA233259, 5P01CA129243, and The Phran Galante Research Funds. Here, EGFR is linked to lung carcinoma.